Could AI Plus Lasers Help Catch Very Early Breast Cancers?
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Dec. 26, 2025 -- Very early-stage breast cancers are notoriously tough to spot via mammograms, but new technology might make detection easier.
According to a new study published recently in the Journal of Biophotonics, Scottish researchers are combining AI with high-tech "laser analysis" to spot changes in circulating blood that could signal the earliest stages of breast tumors.
Innovations like these could end up saving cancer patients' lives, said lead study author Andy Downes, a senior lecturer in engineering at the University of Edinburgh in Scotland.
“Most deaths from cancer occur following a late-stage diagnosis after symptoms become apparent, so a future screening test for multiple cancer types could find these at a stage where they can be far more easily treated," Downes noted in a university news release.
The small study involved 24 blood samples: 12 obtained from breast cancer patients and 12 from healthy people.
The new technology involves subjecting the blood's plasma to laser beam analysis (a technology called Raman spectroscopy) and then using a device called a spectrometer to analyze the ways in which laser light interacts with the blood.
As Downes' team explained, even tiny shifts in the chemical make-up of cells and tissues under spectroscopy can provide clues to where cancer is present.
AI is then used to help quickly and accurately interpret the findings.
The result: In this small study, at least, the new technology was 98% effective in spotting stage 1a breast cancers, the very earliest stage.
Beyond that, the strategy was 90% effective in differentiating between the 4 major subtypes of breast cancer.
Knowing the exact type of cancer a person has, at a very early stage, makes decisions around treatment easier and could save lives.
Downes explained that the findings are still early, but could have implications that reach far beyond breast cancer.
"Early diagnosis is key to long-term survival, and we finally have the technology required," Downes concluded. "We just need to apply it to other cancer types and build up a database, before this can be used as a multi-cancer test.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-27 00:00
Read more
- Breast Cancer Risk Increased With Weight Gain After Age 35 Years
- Blood Test Might Alert Doctors to Problem Drinking
- FDA Grants Revascor (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
- Stroke Survivors Face Much Higher Odds for Dementia
- Coffee Linked to Higher Cognitive Performance in Seniors With A-Fib
- FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions